BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18038215)

  • 1. Aspirin: recent developments.
    Yasuda O; Takemura Y; Kawamoto H; Rakugi H
    Cell Mol Life Sci; 2008 Feb; 65(3):354-8. PubMed ID: 18038215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.
    Rimon G; Sidhu RS; Lauver DA; Lee JY; Sharma NP; Yuan C; Frieler RA; Trievel RC; Lucchesi BR; Smith WL
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):28-33. PubMed ID: 19955429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A 100 years of aspirin: a drug with a future?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclooxygenase inhibition in patients with coronary artery disease.
    Frishman WH
    J Am Coll Cardiol; 2004 Feb; 43(4):532-3. PubMed ID: 14975459
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.
    Umar A; Steele VE; Menter DG; Hawk ET
    Semin Oncol; 2016 Feb; 43(1):65-77. PubMed ID: 26970125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are all the things that aspirin does?
    Flower R
    BMJ; 2003 Sep; 327(7415):572-3. PubMed ID: 12969898
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aspirin, pain and inflammation].
    Vergne P; Bertin P; Trèves R
    Rev Med Interne; 2000 Mar; 21 Suppl 1():89s-96s. PubMed ID: 10763210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.
    Hohlfeld T; Saxena A; Schrör K
    Thromb Haemost; 2013 May; 109(5):825-33. PubMed ID: 23238666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin: old drug, new uses and challenges.
    Yeomans ND
    J Gastroenterol Hepatol; 2011 Mar; 26(3):426-31. PubMed ID: 21062358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects.
    Mehta JL
    Clin Cardiol; 1998 Dec; 21(12):879-84. PubMed ID: 9853178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin resistance: does it exist and is it an important clinical problem?
    Eikelboom J
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):268-70. PubMed ID: 16728937
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin for the second hundred years: new uses for an old drug.
    Vainio H; Morgan G
    Pharmacol Toxicol; 1997 Oct; 81(4):151-2. PubMed ID: 9353843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and its rivals. As your options increase, your choices get harder.
    Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131
    [No Abstract]   [Full Text] [Related]  

  • 15. COX-2 selective NSAIDs.
    Ryan NS
    Cleve Clin J Med; 2000 Jan; 67(1):67. PubMed ID: 10645679
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin and cyclooxygenase-2 inhibitors.
    Armstrong TA
    Am J Health Syst Pharm; 2003 Jul; 60(14):1481. PubMed ID: 12892035
    [No Abstract]   [Full Text] [Related]  

  • 17. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin: new cardiovascular uses for an old drug.
    Patrono C
    Am J Med; 2001 Jan; 110(1A):62S-65S. PubMed ID: 11166001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aspirin against cancer].
    Mabro M; de Gramont A
    Rev Med Interne; 2000 Mar; 21 Suppl 1():60s-67s. PubMed ID: 10763206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.